The Vaccine Group (TVG) has agreed a collaboration with the world-leading Pirbright Institute to develop a vaccine to combat type-1 PRRSV disease, as part of an 18-month development project funded by ECO Animal Health (EAH-LON). PRRSV is a viral disease causing reproductive failure and often fatal respiratory disease in pigs. PRRSV is one of the most economically significant disease affecting swine production, costing pig producers over >$600m in the US and >€1.5bn in Europe each year. Investing ....
15 Oct 2020
TVG vaccine collaboration with ECO and Pirbright
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
TVG vaccine collaboration with ECO and Pirbright
Frontier IP Group Plc (FIPP:LON) | 38.5 0 0.0% | Mkt Cap: 21.6m
- Published:
15 Oct 2020 -
Author:
Edward Thomason -
Pages:
3
The Vaccine Group (TVG) has agreed a collaboration with the world-leading Pirbright Institute to develop a vaccine to combat type-1 PRRSV disease, as part of an 18-month development project funded by ECO Animal Health (EAH-LON). PRRSV is a viral disease causing reproductive failure and often fatal respiratory disease in pigs. PRRSV is one of the most economically significant disease affecting swine production, costing pig producers over >$600m in the US and >€1.5bn in Europe each year. Investing ....